Form S-8 - Securities to be offered to employees in employee benefit plans:
SEC Accession No. 0000950170-25-103078
Filing Date
2025-08-05
Accepted
2025-08-05 16:19:07
Documents
16
Effectiveness Date
2025-08-05

Document Format Files

Seq Description Document Type Size
1 S-8 idya-20250805.htm S-8 137061
2 EX-5.1 idya-ex5_1.htm EX-5.1 31235
3 EX-23.1 idya-ex23_1.htm EX-23.1 3932
4 EX-FILING FEES idya_exfilingfees.htm   iXBRL EX-FILING FEES 69617
5 GRAPHIC img113933597_0.jpg GRAPHIC 20715
6 GRAPHIC img113933597_1.jpg GRAPHIC 18549
  Complete submission text file 0000950170-25-103078.txt   426445

Data Files

Seq Description Document Type Size
18 EXTRACTED XBRL INSTANCE DOCUMENT idya_exfilingfees_htm.xml XML 8953
Mailing Address 5000 SHORELINE CT, SUITE 300 SOUTH SAN FRANCISCO CA 94080
Business Address 5000 SHORELINE CT, SUITE 300 SOUTH SAN FRANCISCO CA 94080 650-443-6209
IDEAYA Biosciences, Inc. (Filer) CIK: 0001676725 (see all company filings)

EIN.: 474268251 | State of Incorp.: DE | Fiscal Year End: 1231
Type: S-8 | Act: 33 | File No.: 333-289256 | Film No.: 251185275
SIC: 2834 Pharmaceutical Preparations
(CF Office: 03 Life Sciences)